focus -WSS

focus

author：focus 2025-09-27 22:48:25 - browse：831

LONDON — AstraZeneca said Friday an experimental drug tamped down the progression of a certain type of breast cancer in a Phase 3 trial, a win for the company after the same drug produced underwhelming results in a lung cancer trial over the summer.

The drug, called datopotamab deruxtecan or Dato-DXd for short, succeeded on one of its primary endpoints of improving progression-free survival compared to chemotherapy in certain breast cancer patients who had previously been treated with other therapies.

AstraZeneca, which is developing Dato-DXd with partner Daiichi Sankyo, said that the data for the other primary endpoint of overall survival were not “mature” as of this interim analysis, but that there was a positive trend. The trial is continuing.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Beware the threat of staffing cuts at the CDC

knowledge

WSS

The pain doctors face in trying to build their families

FDA approves first treatment for ultra

Sen. Paul opposes bill to ban Chinese biotechs

New definition of a human embryo proposed amid rapid advances

Living with Hashimoto's and celiac disease, and med school, too

New details revealed about Purdue's marketing of OxyContin

focus

focus

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Anesthesiologist group: stop taking Ozempic before surgery

Cancer drug shortages' outsize impact on ovarian cancer patients

Guidelines to prevent youth baseball injuries need more muscle

Just how do doctors, lawmakers, and the public define abortion?

Novavax promises a turnaround & Lilly roils the obesity market

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Virginia high school admissions case could be legal follow

Cancer drug shortages' outsize impact on ovarian cancer patients

entertainment

What it’s like to watch children die of measles

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Trump cancels press conference intended to dispute Georgia election interference charges

The problem with charging patients to message their doctors

Trump's false claims about Georgia's 2020 election long debunked

Beware the threat of staffing cuts at the CDC

knowledge

Wikipedia

explore

leisure time